Brent Bankosky Joins American Diabetes Association in Support of Louisiana Senate Bill 759
New York, NY (PRWEB) July 10, 2012
As obesity rates climb in America, so does the number of people who suffer from the debilitating disease known as diabetes. While many overweight adults are afflicted with pre-diabetes and Type 2 diabetes, younger otherwise healthy school-aged children begin to suffer from Type 1 diabetes that requires life-long care. Although Type 2 diabetes can usually be managed with oral medication, diet and exercise, the treatment conditions for Type 1 diabetic patients are often much more severe. Type 1 diabetics usually acquire the disease that attacks insulin production through genetic anomalies rather than through an inability to sustain a healthy weight and diet. Brent Bankosky, a pharmaceutical professional with extensive experience in diabetes drug development, adds that these individuals must administer insulin injections several times a day, regardless of diet and exercise.
He adds that these patients must also observe the threat of low blood sugar, and in severe cases inject a drug called glucagon to raise those levels. These procedures are particularly difficult for children, and sometimes require help from a trained adult. However, according to a recent article from The Wall Street Journal, parents and caretakers are not always available to help with medication delivery. The Louisiana Senate passed Bill 759 in an effort to help train school volunteers on proper treatment for diabetic students while they spend their days at academic institutions.
Bankosky explains exactly what the bill implies, “The law goes further to allow students to possess the necessary tests and supplies for monitoring and treatment of their diabetes, administering blood-glucose tests on school premises, allows for self-administration of glucagon or insulin and gives students the ability to manage possible hypoglycemia and hyperglycemia conditions as specified in the student’s treatment management plan. Students may not be denied assignment from a particular public school based on the premise that the school does not have an unlicensed diabetes care assistant.”
Since the disease is very complicated and varies for each affected patient, it requires extensive diabetes education and nutritional information. Bankosky indicates that the drugs currently available, including insulin, are sometimes painful and maintenance-heavy, but help individuals avoid serious medical complications.
Brent Bankosky adds that the Louisiana Senate Bill 759 gives students the necessary support that they need during their fragile years. He encourages further implementation of similar laws, “This new law represents a practical approach to the treatment and management of diabetes for school-aged children and should serve as a working model for other states to enact such laws to help students identify, manage and treat Type 1 and Type 2 diabetes.”
Brent Bankosky is a business development and corporate strategy executive who has a strong background in the pharmaceutical industry. Through his work, he has assisted multiple companies in the development and strategy associated with pharmaceutical products. Additionally, Brent Bankosky has accrued global experience, allowing him to understand the international implications of innovations within the pharmaceutical industry, as well as work well with professionals from a variety of backgrounds and cultures.